Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem-zidebactam vs Ceftazidime-Avibactam in cUTI or AP
NCT07840105Phase 2Not yet recruiting
- Sponsor
- Wockhardt
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of WCK 6777 in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Wockhardt. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
WCK 6777
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT07840105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07840105.